(Alliance News) - Hemogenyx Pharmaceuticals PLC on Wednesday said the third patient has been successfully treated in an ongoing phase 1 clinical trial for a form of leukaemia.

Barratt Redrow says its profit beat guidance despite home completions falling short, Moonpig affirms guidance, and Galliford Try announces a new buyback. Here is what you need to know before the ...